These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 398513)

  • 1. Low dose steroid from the day following renal transplantation.
    McGeown MG; Douglas JF; Brown WA; Donaldson RA; Kennedy JA; Loughridge WG; Mehta S; Hill CM
    Proc Eur Dial Transplant Assoc; 1979; 16():395-400. PubMed ID: 398513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year results of renal transplantation using only azathioprine and low-dose prednisolone as immunosuppression.
    McGeown MG; Doherty CC; Douglas JF; Donaldson RA; Hill CM; Kennedy JA; Loughridge WG; Middletown D
    Clin Transpl; 1989; ():191-9. PubMed ID: 2487566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of renal transplantation five to twenty-six years after surgery, using azathioprine and low-dose prednisolone as sole immunosuppression.
    McGeown MG; Craig WJ
    Clin Transpl; 1996; ():265-70. PubMed ID: 9286576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages of low dose steroid from the day after renal transplantation.
    McGeown MG; Douglas JF; Brown WA; Donaldson RA; Kennedy JA; Loughridge WG; Mehta S; Nelson SD; Doherty CC; Johnstone R; Todd G; Hill CM
    Transplantation; 1980 Apr; 29(4):287-89. PubMed ID: 6989048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
    Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
    Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Triple immunosuppression in renal transplantation in children: 3 years' experience].
    Trompeter RS
    Pediatrie; 1989; 44(2):87-91. PubMed ID: 2654877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
    Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
    Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney allograft outcome in simultaneous pancreas-kidney transplantation.
    Nakache R; Weinbroum A; Merhav H; Kaplan E; Kariv Y; Khoury W; Gutman M; Klausner JM
    Isr Med Assoc J; 2000 Jul; 2(7):517-9. PubMed ID: 10979325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients.
    Cueto-Manzano AM; Konel S; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
    Transplantation; 2003 Jun; 75(12):2053-8. PubMed ID: 12829911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 19. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.